🇺🇸 FDA
Pipeline program

EXPAREL 20 mL

MA402S23B701

Approved small_molecule completed

Quick answer

EXPAREL 20 mL for Postsurgical Pain is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Postsurgical Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials